RATIONALE AND OBJECTIVES:To evaluate the feasibility of mechanical thrombectomy with the Amplatz thrombectomy device (ATD) in restoring patency of acutely thrombosed pulmonary arteries resulting from pulmonary embolism for the improvement of patient outcome. METHODS:Mechanical thrombectomy with the ATD (8F) was performed in nine consecutive patients with angiographically documented thrombus in the left or right pulmonary artery resulting from deep vein thrombosis (n = 4) or unknown cause (n = 5). RESULTS:The Miller index decreased from 18 to 11. In all patients, the majority of the thrombus in the pulmonary artery was cleared after a mean activation time of the ATD of 367 seconds. Thrombectomy was performed with the ATD alone (n = 4) or with additional long-term fibrinolysis therapy (n = 5) with infusion of recombinant tissue-type plasminogen activator. Pulmonary arterial pressure decreased from a mean of 57 mm Hg before mechanical thrombectomy to 55 mm Hg directly after the procedure and to 39 mm Hg after termination of the recombinant tissue-type plasminogen activator infusion. CONCLUSIONS:Mechanical thrombectomy with the ATD in patients with minor and major pulmonary embolism is technically feasible and safe. It is a potential alternative to drug-mediated thrombolysis and surgery. However, the incremental benefit of the ATD over conventional treatments could be shown only in a randomized controlled study.

译文

理由和目的:评估使用Amplatz血栓切除术装置(ATD)进行机械血栓切除术,以恢复由肺栓塞引起的急性血栓形成的肺动脉通畅以改善患者预后的可行性。
方法:对9例因深静脉血栓形成(n = 4)或原因不明(n = 5)而在血管造影上记录的左或右肺动脉血栓的患者,进行了ATD(8F)机械血栓切除术。
结果:米勒指数从18降低至11。在所有患者中,平均ATD激活时间为367秒后,大部分肺动脉血栓被清除。单独使用ATD(n = 4)或进行其他长期纤溶治疗(n = 5),并注入重组组织型纤溶酶原激活剂,即可行血栓切除术。肺动脉压从机械血栓切除术前的平均57 mm Hg降低到手术后的55 mm Hg,而在重组组织型纤溶酶原激活剂输注终止后降低到39 mm Hg。
结论:对于轻度和重度肺动脉栓塞患者,采用ATD机械血栓切除术在技术上是可行和安全的。它是药物介导的溶栓和手术的潜在替代方法。但是,只有在随机对照研究中才能显示出ATD优于传统疗法的益处。

+1
+2
100研值 100研值 ¥99课程
检索文献一次
下载文献一次

去下载>

成功解锁2个技能,为你点赞

《SCI写作十大必备语法》
解决你的SCI语法难题!

技能熟练度+1

视频课《玩转文献检索》
让你成为检索达人!

恭喜完成新手挑战

手机微信扫一扫,添加好友领取

免费领《Endnote文献管理工具+教程》

微信扫码, 免费领取

手机登录

获取验证码
登录